110 related articles for article (PubMed ID: 3250240)
21. Pro-oxidant effects of cross-linked haemoglobins explored using liposome and cytochrome c oxidase vesicle model membranes.
Rogers MS; Patel RP; Reeder BJ; Sarti P; Wilson MT; Alayash AI
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):827-33. PubMed ID: 7575415
[TBL] [Abstract][Full Text] [Related]
22. Stability and blood compatibility of polylipid/Hb.
Morizawa K; Akama K; Kawakami Y; Tsuchida E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):641-5. PubMed ID: 1391488
[TBL] [Abstract][Full Text] [Related]
23. Liposome-encapsulated hemoglobin: historical development of a blood substitute.
Goins B; Rudolph AS; Ligler FS
Biotechnology; 1991; 19():117-25. PubMed ID: 1786468
[No Abstract] [Full Text] [Related]
24. Use of oxygen-15-labeled molecular oxygen for oxygen delivery studies of blood and blood substitutes.
Goins B; Klipper R; Martin C; Jerabek PA; Khalvati S; Fox PT; Cliff RO; Kwasiborski V; Rudolph AS; Phillips WT
Adv Exp Med Biol; 1998; 454():643-52. PubMed ID: 9889945
[No Abstract] [Full Text] [Related]
25. Modification of human hemoglobin with polyethylene glycol : a new candidate for blood substitute.
Ajisaka K; Iwashita Y
Biochem Biophys Res Commun; 1980 Dec; 97(3):1076-81. PubMed ID: 7470134
[No Abstract] [Full Text] [Related]
26. Approach to clinical trial considering medical ethics and efficacy for HbV, liposome encapsulated hemoglobin vesicle.
Takaori M
Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):65-73. PubMed ID: 15768566
[TBL] [Abstract][Full Text] [Related]
27. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
[TBL] [Abstract][Full Text] [Related]
28. [Oxygen transport in rats following total blood replacement with solutions of high-molecular modified hemoglobin].
Ivanov KP; Samsonov GV; Bogomolova LG; Moiseeva OI; Chuikin AE
Fiziol Zh SSSR Im I M Sechenova; 1981 Dec; 67(12):1814-22. PubMed ID: 7333374
[TBL] [Abstract][Full Text] [Related]
29. Increased viscosity of hemoglobin-based oxygen carriers retards NO-binding when perfused through narrow gas-permeable tubes.
Sakai H; Okuda N; Takeoka S; Tsuchida E
Microvasc Res; 2011 Mar; 81(2):169-76. PubMed ID: 21167845
[TBL] [Abstract][Full Text] [Related]
30. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats.
Sakai H; Takeoka S; Park SI; Kose T; Nishide H; Izumi Y; Yoshizu A; Kobayashi K; Tsuchida E
Bioconjug Chem; 1997; 8(1):23-30. PubMed ID: 9026031
[TBL] [Abstract][Full Text] [Related]
31. Preparation of carboxymethylchitin-incorporated submicron bilayer-lipid membrane artificial cells (liposomes) encapsulating hemoglobin.
Mobed M; Nishiya T; Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):365-8. PubMed ID: 1391452
[No Abstract] [Full Text] [Related]
32. Synthesis and characterization of artificial red cell (ARC).
Tsuchida E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):337-44. PubMed ID: 1391449
[TBL] [Abstract][Full Text] [Related]
33. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
[TBL] [Abstract][Full Text] [Related]
34. [Interaction of hemoglobin with phospholipid vesicular membranes of different composition].
Bondarenko SV; Ushakova IP; Levit LF; Serebrennikova GA; Evstigneeva RP
Bioorg Khim; 1985 Oct; 11(10):1385-90. PubMed ID: 4074398
[TBL] [Abstract][Full Text] [Related]
35. Properties of chemically cross-linked hemoglobin solutions designed as temporary oxygen carriers.
Keipert PE
Adv Exp Med Biol; 1992; 317():453-64. PubMed ID: 1288157
[No Abstract] [Full Text] [Related]
36. Purification and quantitative determination of carboxymethylchitin incorporation into submicron bilayer-lipid membrane artificial cells (liposomes) encapsulating hemoglobin.
Mobed M; Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):369-76. PubMed ID: 1391453
[TBL] [Abstract][Full Text] [Related]
37. [Synthetic models of erythrocytes--hemosomes].
Kol'tsova GN; Vashkevich MG; Rozenberg GIa
Gematol Transfuziol; 1984 Jun; 29(6):50-4. PubMed ID: 6381220
[No Abstract] [Full Text] [Related]
38. Kinetics of oxygen and carbon monoxide binding to synthetic analogs of the myoglobin and hemoglobin active sites.
Chang CK; Traylor TG
Proc Natl Acad Sci U S A; 1975 Mar; 72(3):1166-70. PubMed ID: 1055374
[TBL] [Abstract][Full Text] [Related]
39. [A nondestructive method to measure the oxygen binding and releasing properties of biodegradable polymers microcapsules intented for blood substitutes].
Zhang X; Yuan Y; Wang K; Shan X; Zhao J; Sheng Y; Liu C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Oct; 25(5):1116-20. PubMed ID: 19024458
[TBL] [Abstract][Full Text] [Related]
40. Artificial cells with ultrathin lipid-polymer or lipid-protein membranes.
Chang TM
Adv Exp Med Biol; 1988; 238():215-23. PubMed ID: 3074637
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
